Certara (NASDAQ:CERT) Now Covered by TD Cowen

Research analysts at TD Cowen started coverage on shares of Certara (NASDAQ:CERT) in a report issued on Thursday,Briefing.com Automated Import reports. The firm set a “buy” rating and a $16.00 price target on the stock. TD Cowen’s price objective would suggest a potential upside of 29.76% from the company’s current price.

Other equities analysts have also issued research reports about the stock. Robert W. Baird dropped their target price on shares of Certara from $18.00 to $13.00 and set a “neutral” rating on the stock in a report on Tuesday, November 5th. Barclays cut their target price on Certara from $14.00 to $12.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 7th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $15.42.

Certara Stock Down 0.4 %

Shares of NASDAQ CERT opened at $12.33 on Thursday. The company’s 50 day moving average price is $12.39 and its 200-day moving average price is $11.63. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.86 and a current ratio of 2.86. Certara has a 52-week low of $9.41 and a 52-week high of $19.87. The company has a market capitalization of $1.98 billion, a P/E ratio of -61.65, a price-to-earnings-growth ratio of 9.29 and a beta of 1.57.

Institutional Investors Weigh In On Certara

Several hedge funds and other institutional investors have recently modified their holdings of CERT. Vanguard Group Inc. grew its position in Certara by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 12,437,089 shares of the company’s stock valued at $132,455,000 after purchasing an additional 38,068 shares during the period. Wasatch Advisors LP grew its holdings in shares of Certara by 22.4% during the third quarter. Wasatch Advisors LP now owns 9,015,941 shares of the company’s stock valued at $105,577,000 after buying an additional 1,651,076 shares during the last quarter. ArrowMark Colorado Holdings LLC increased its position in shares of Certara by 164.2% during the fourth quarter. ArrowMark Colorado Holdings LLC now owns 6,213,278 shares of the company’s stock worth $66,171,000 after acquiring an additional 3,861,674 shares in the last quarter. Geneva Capital Management LLC raised its holdings in shares of Certara by 0.7% in the 3rd quarter. Geneva Capital Management LLC now owns 5,510,209 shares of the company’s stock worth $64,525,000 after acquiring an additional 37,392 shares during the last quarter. Finally, Teacher Retirement System of Texas lifted its position in Certara by 13.9% in the 4th quarter. Teacher Retirement System of Texas now owns 4,557,951 shares of the company’s stock valued at $48,542,000 after acquiring an additional 557,348 shares in the last quarter. Institutional investors own 73.96% of the company’s stock.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.